wow what an AGMSo detailed, completely blew me away... I loved the question and answer session too... line after line of imvestors asking questions, and the management team went out of their way to paint a picture of certain future success...
well, we can all dream can't we... another presentation, and ONCY is declining again...
From all the recent Q&As however, it is most apparent that ONCY will not be going ahead with a CPI until a partner can see clear evidence of differentiation of OS between the doublet and triplet... We're only now at the stage where ONCY is duplicating the results of IND-213. That is excellent news anyway, but they still need someone to fund the phase III... OR they (WE) wait another 9 months until Q1 2024, to know if it is even worth adding a CPI.
I agree with others commentary here and other boards that ONCY is signalling that they will be going for a PIII without a CPI. Pretty much all patients on the triplet would still have to be alive as of now in order to think adding a CPI was worth it... so sorry folks, but we've wasited 5 years since IND-213 to say, yep, the results were valid... what a sh& tshow.